-Paul B Fisher Researcher Activity Profile

Research Author Detailed Information 

Paul B Fisher Publication Rate By Year

Paul B Fisher has published 11 paper(s) in 2006, 23 paper(s) in 2007, 13 paper(s) in 2008, for a total of 47 research publications in total.

Paul B Pb Fisher Author Information

LAST NAME: fisher

FIRST NAME: Paul B

INITIALS: pb

AFFILIATION:

Papers

Paul B Fisher's Publication Record

1. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway. Year Published: 2007
Division of Human Gene Therapy, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama 35294-2172, USA.
2. Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy? Year Published: 2007
Columbia University Medical Center, Department of Urology, College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA. ds2039@columbia.edu
3. Defining the mechanism by which IFN-beta dowregulates c-myc expression in human melanoma cells: pivotal role for human polynucleotide phosphorylase (hPNPaseold-35). Year Published: 2006
Department of Pathology, Herbert Irving Comprehensive Caner Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA.
4. BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Year Published: 2006
Department of Pathology, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA.
5. Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Year Published: 2006
Department of Viral Diseases and Immunology, National Public Health Institute, Helsinki, Finland.
6. Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus. Year Published: 2006
Division of Neurosurgery, The University of Chicago, MC 3026, Chicago, IL 60637, USA.
7. Discovering innate immunity genes using differential display: a story of RNA helicases. Year Published: 2006
Center for Infectious Disease and Vaccine Research, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
8. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Year Published: 2006
Department of Urology, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA.
9. Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy. Year Published: 2006
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York 10032, USA.
10. N-glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and "bystander" antitumor activity. Year Published: 2006
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York 10032, USA.
11. A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells. Year Published: 2006
BIDMC Genomics Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA.
12. Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment. Year Published: 2006
Department of Biochemistry, 401 College St., Massey Cancer Center, Room 2-108, Box 980035, Virginia Commonwealth University, Richmond VA 23298-0035, USA.
13. MEK1/2 inhibition promotes Taxotere lethality in mammary tumors in vivo. Year Published: 2006
Department of Biochemistry, Virginia Commonwealth University, Richmond, Virginia 23298, USA.
14. Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells. Year Published: 2007
Department of Pathology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA.
15. Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. Year Published: 2007
Department of Microbiology and Immunology and Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL 33136, USA.
16. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Year Published: 2007
Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
17. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Year Published: 2007
Departments of Urology, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University Medical Center, 630 West 168th Street, New York, NY 10032, USA.
18. Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas. Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
19. Radiation-induced cell signaling: inside-out and outside-in. Year Published: 2007
Department of Biochemistry, Virginia Commonwealth University, 401 College Street, Box 980035, Richmond, VA 23298, USA.
20. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus. Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York 10032, USA.
21. Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinase signaling. Year Published: 2007
Department of Biochemistry, Virginia Commonwealth University, Richmond, VA 23298-0035, USA.
22. Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York 10032, USA.
23. Activation of double-stranded RNA dependent protein kinase, a new pathway by which human polynucleotide phosphorylase (hPNPase(old-35)) induces apoptosis. Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Caner Center, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA. ds2039@columbia.edu
24. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA.
25. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma. Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA. pbf1@columbia.edu
26. Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells. Year Published: 2007
Departments of Pathology and Urology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032. pbf1@columbia.edu.
27. Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells. Year Published: 2007
Department of Biochemistry, Box 980035, Virginia Commonwealth University, Richmond, VA 23298-0035. pdent@vcu.edu.
28. Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells. Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA.
29. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA.
30. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma. Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA. pbf1@columbia.edu
31. Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York 10032, USA.
32. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway. Year Published: 2007
Division of Human Gene Therapy, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama 35294-2172, USA.
33. Reciprocal subtraction differential RNA display (RSDD): an efficient technology for cloning differentially expressed genes. Year Published: 2008
Department of Urology, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY, USA.
34. Cloning differentially expressed genes using rapid subtraction hybridization (RaSH). Year Published: 2008
Department of Pathology, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY, USA.
35. Complete open reading frame (C-ORF) technique: rapid and efficient method for obtaining complete protein coding sequences. Year Published: 2008
Hallym University, Ilsong Institute of Life Science, Anyang, Kyeonggi-do, Republic of Korea.
36. Surface-epitope masking (SEM): an immunological subtraction approach for developing monoclonal antibodies targeting surface-expressed molecules. Year Published: 2008
Antyra, Inc., Edison, NJ, USA.
37. Approaches for monitoring signal transduction changes in normal and cancer cells. Year Published: 2008
Department of Biochemistry, Virginia Commonwealth University, Richmond, USA.
38. Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells. Year Published: 2007
Department of Biochemistry, Box 980035, Virginia Commonwealth University, Richmond, VA 23298-0035, USA.
39. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Year Published: 2008
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA.
40. Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells. Year Published: 2007
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA.
41. Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells. Year Published: 2008
Department of Biochemistry, Virginia Commonwealth University, 401 College Street, Massey Cancer Center, Box 980035, Richmond, VA 23298-0035. pdent@vcu.edu.
42. Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling. Year Published: 2008
Department of Biochemistry, Virginia Commonwealth University, 401 College Street, Massey Cancer Center, Box 980035, Richmond, VA 23298-0035. pdent@vcu.edu.
43. Progression elevated gene-3 promoter (PEG-Prom) confers cancer cell selectivity to human polynucleotide phosphorylase (hPNPase(old-35))-mediated growth suppression. Year Published: 2008
College of Physicians and Surgeons, Columbia University Medical School, New York, New York, USA.
44. PERK-dependent regulation of HSP70 expression and the regulation of autophagy. Year Published: 2008
Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia, USA.
45. Phagocytosis of picornavirus-infected cells induces an RNA-dependent antiviral state in human dendritic cells. Year Published: 2008
Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Geert Grooteplein 28, 6525 GA, Nijmegen, The Netherlands.
46. Targeted combinatorial therapy of non-small cell lung carcinoma using a GST-fusion protein of full-length or truncated MDA-7/IL-24 with Tarceva. Year Published: 2008
Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.
47. OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells. Year Published: 2008
Department of Biochemistry, 401 College Street, Massey Cancer Center, Room 280a, Box 980035, Virginia Commonwealth University, Richmond, VA 23298-0035, USA.